The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

Awiqli(R) (insulin icodec-abae) injection is the first-ever once-weekly basal insulin approved by the FDA1 -- Awiqli(R) offers adults with type 2 diabetes an alternative to daily basal insulin ...

March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control ...

More than 1 in 10 Americans have diabetes—that’s a lot of people. But diabetes isn’t just one universal condition. There are many different types. All types involve problems with blood sugar ...

Insulin therapy helps control blood sugar levels in diabetes. What type of insulin you take, how often you take it, and how it’s administered are all part of your individualized treatment plan. For ...

Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day, to help ...

Add Yahoo as a preferred source to see more of our stories on Google. Each year, 1.4 million people are diagnosed with diabetes mellitus in the U.S., according to the association. Despite the ...

Add Yahoo as a preferred source to see more of our stories on Google. While nearly 40 million people in the US suffer from diabetes, some 8.7 million of them don’t even know they have the condition, ...

Type 2 diabetes is the most common kind of diabetes. Lifestyle factors such as diet and exercise, genetics, and some medications can cause you to develop the condition. It’s sometimes called ...

FDA approves 1st weekly basal insulin, Awiqli, offering adults with Type 2 diabetes a once-weekly injection to improve ...